A laboratory-based research and development component of the HVTN is based in the McElrath laboratory. These investigations include assessment of new assays that can be developed and implemented into vaccine trials. Additional studies center upon the immunogencity of clinical vaccines in clinical protocols.
Publications:
N. Russell, M. Hudgens, R. Ha, C. Havenar-Daughton, and M.J. McElrath . Moving to HIV vaccine efficacy trials: defining T cell responses as potential correlates of immunity. In press, J Infect Dis.
